Anti-SLAMF7 CAR T cells
/ National Cancer Center, University of Wuerzburg
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 23, 2021
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
(clinicaltrials.gov)
- P1; N=13; Completed; Sponsor: National Cancer Institute (NCI); Trial primary completion date: Jan 2021 ➔ Oct 2020
Clinical • Trial primary completion date • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1